| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $1.32 | $39.6k | | 05/26/2023 |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/26/2023 |
| 11/17/2022 | SOLIGENIX, INC. | SNGX | Grant | Stock Option (Right to Buy) | 46.2k | $0.65 | $30k | | 11/17/2022 |
| 06/09/2022 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 8.3k | $0.00 | $0 | | 06/09/2022 |
| 06/09/2022 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 8.3k | $2.99 | $24.9k | | 06/09/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/20/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $2.01 | $60.3k | | 05/20/2022 |
| 09/23/2021 | SOLIGENIX, INC. | SNGX | Grant | | 29.1k | $1.03 | $30k | | 09/23/2021 |
| 06/02/2021 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 100k | $2.04 | $204k | | 06/02/2021 |
| 05/19/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/19/2021 |
| 05/19/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $3.64 | $109.2k | | 05/19/2021 |
| 09/16/2020 | SOLIGENIX, INC. | SNGX | Grant | | 15.2k | $1.97 | $30k | | 09/16/2020 |
| 06/11/2020 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 7.5k | $6.17 | $46.3k | | 06/11/2020 |
| 05/15/2020 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 55k | $1.77 | $97.1k | | 05/15/2020 |
| 09/06/2019 | SOLIGENIX, INC. | SNGX | Grant | | 30.9k | $0.97 | $30k | | 09/06/2019 |
| 05/23/2019 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 55k | $2.02 | $111.1k | | 05/23/2019 |
| 02/13/2019 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 12.2k | $4.39 | $53.6k | | 02/13/2019 |
| 01/03/2019 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 2.8k | $0.00 | $0 | | 01/03/2019 |
| 01/03/2019 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 2.8k | $4.90 | $13.7k | | 01/03/2019 |
| 09/27/2018 | SOLIGENIX, INC. | SNGX | Grant | | 18k | $1.67 | $30k | | 09/27/2018 |
| 05/17/2018 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $3.98 | $119.4k | | 05/17/2018 |
| 10/31/2017 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 80k | $3.80 | $304k | | 10/31/2017 |
| 06/08/2017 | SCICLONE PHARMACEUTICALS INC | SCLN | Grant | | 30k | $10.90 | $327k | | 06/08/2017 |
| 06/08/2017 | SOLIGENIX, INC. | SNGX | Grant | | 13.1k | $2.29 | $30k | | 06/08/2017 |
| 06/09/2016 | SCICLONE PHARMACEUTICALS INC | SCLN | Grant | | 30k | $14.00 | $419.8k | | 06/09/2016 |
| 01/01/2010 | QUESTCOR PHARMACEUTICALS INC | QCOR | Grant | | 15k | $4.75 | $71.2k | | 01/01/2010 |
| 01/01/2010 | QUESTCOR PHARMACEUTICALS INC | QCOR | Grant | | 10k | $4.75 | $47.5k | | 01/01/2010 |